Liu Yawen, Vandekeere Anke, Xu Min, Fendt Sarah-Maria, Altea-Manzano Patricia
Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, China.
Laboratory of Cellular Metabolism and Metaboli Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
Front Oncol. 2022 Sep 23;12:988626. doi: 10.3389/fonc.2022.988626. eCollection 2022.
Malignant growth is defined by multiple aberrant cellular features, including metabolic rewiring, inactivation of tumor suppressors and the activation of oncogenes. Even though these features have been described as separate hallmarks, many studies have shown an extensive mutual regulatory relationship amongst them. On one hand, the change in expression or activity of tumor suppressors and oncogenes has extensive direct and indirect effects on cellular metabolism, activating metabolic pathways required for malignant growth. On the other hand, the tumor microenvironment and tumor intrinsic metabolic alterations result in changes in intracellular metabolite levels, which directly modulate the protein modification of oncogenes and tumor suppressors at both epigenetic and post-translational levels. In this mini-review, we summarize the crosstalk between tumor suppressors/oncogenes and metabolism-induced protein modifications at both levels and explore the impact of metabolic (micro)environments in shaping these.
恶性肿瘤生长由多种异常细胞特征所定义,包括代谢重编程、肿瘤抑制因子失活和癌基因激活。尽管这些特征被描述为独立的标志,但许多研究表明它们之间存在广泛的相互调节关系。一方面,肿瘤抑制因子和癌基因表达或活性的变化对细胞代谢具有广泛的直接和间接影响,激活恶性肿瘤生长所需的代谢途径。另一方面,肿瘤微环境和肿瘤内在代谢改变导致细胞内代谢物水平变化,这在表观遗传和翻译后水平直接调节癌基因和肿瘤抑制因子的蛋白质修饰。在本综述中,我们总结了肿瘤抑制因子/癌基因与代谢诱导的蛋白质修饰在这两个水平上的相互作用,并探讨了代谢(微)环境在塑造这些作用方面的影响。